Pfizer Inc., announced the successful completion of its acquisition of Seagen Inc., a global biotechnology company that discovers, develops and commercializes transformative cancer medicines....
Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be presenting at the 2023 Life Sciences Summit hosted by...
Biotech Acquisition Company, a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based...
Biotech Acquisition Company, a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based...
Eat Well Investment Group Inc. (“Eat Well” or the “Company”) announces that its principal regulator, the British Columbia Securities Commission, has accepted the Company’s...
